ENVALITH
第一工業製薬株式会社 logo

DKS Co.Ltd.

4461Prime MarketChemicals

第一工業製薬株式会社 logo
DKS Co.Ltd.4461
Reference Indicators

Market Cap

1,131¥100M

P/E (Forecast)

P/B

2.2x

Dividend Yield (Forecast)

1.42%

ROE

13.6%

EV/EBITDA

8.8x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
62,67265,08163,11873,25582,886
Cost of Sales
46,95452,12049,73355,01758,098
Gross Profit
15,71812,96013,38518,23824,787
SG&A Expenses
11,09211,77311,30712,88614,680
Operating Income
4,6261,1862,0775,35110,107
Non-operating Income
319421520782675
Non-operating Expenses
753407537396410
Ordinary Income
4,1921,2002,0605,73710,372
Extraordinary Income
19450408
Extraordinary Losses
2071,027125542480
Pre-tax Income
4,1792242,3435,1949,892
Income Taxes
1,1392747001,3732,592
Net Income
2,492-4071,1742,5856,169
EBITDA
8,2064,6185,2938,57413,328
Gross Margin
25.1%19.9%21.2%24.9%29.9%
Operating Margin
7.4%1.8%3.3%7.3%12.2%
ROA
2.9%-0.5%1.2%2.7%5.4%
ROE
7.0%-1.1%3.3%6.9%13.6%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
電子・情報、環境・エネルギー、ライフ・ウェルネス、コア・マテリアル000.0%
電子・情報30,5076,20320.3%
環境・エネルギー23,3043,14213.5%
ライフ・ウェルネス13,8925994.3%
コア・マテリアル15,1821621.1%